Science
July 17, 2026
Semaglutide Slows Epigenetic Aging Markers in HIV Trial, Study Finds
A randomized controlled trial published in Nature Communications shows the drug reduced biological aging speed by roughly 9% on one epigenetic clock, but the aging analysis was exploratory and post hoc.